Pulmonx Corporation

NASDAQ:LUNG

7.36 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 20.38720.78318.85419.27817.66817.19414.53515.42513.50213.9510.78513.70813.26112.2039.2449.8310.6123.6738.61810.3479.1047.3666.572
Cost of Revenue 5.3615.4764.8764.9784.6394.463.9464.2413.353.5322.6743.4573.5223.1742.6332.7523.152.6612.9683.012.6972.4132.237
Gross Profit 15.02615.30713.97814.313.02912.73410.58911.18410.15210.4188.11110.2519.7399.0296.6117.0787.4621.0125.657.3376.4074.9534.335
Gross Profit Ratio 0.7370.7370.7410.7420.7370.7410.7290.7250.7520.7470.7520.7480.7340.740.7150.720.7030.2760.6560.7090.7040.6720.66
Reseach & Development Expenses 3.7443.8984.213.8964.225.714.2533.9034.3663.5943.5343.7082.8153.5063.0342.4721.9971.4261.5651.6031.3991.4521.524
General & Administrative Expenses 00019.52300015.80800013.80900010.81310.8130010.0248.62100
Selling & Marketing Expenses 0004.80006.10005.10003.1470000.6000
SG&A 25.41125.31424.30424.32323.98523.46322.73621.90819.71721.23520.24518.90916.68617.6215.60413.9610.81311.11210.18910.0248.6218.3577.779
Other Expenses 0-0.0350.415-0.357-0.262-0.1620.1080.201-0.432-0.1650-0.383-0.267-0.0960.1610.232.6310.568-0.1470.096-0.3400
Operating Expenses 29.15529.21228.51428.21928.20529.17326.98925.81124.08324.82923.77922.61719.50121.12618.63816.43212.8112.53811.75411.62710.0210.079.489
Operating Income -14.129-13.905-14.536-13.919-15.176-16.439-16.4-14.627-13.931-14.411-15.668-12.366-9.762-12.097-12.027-9.354-5.348-11.526-6.104-4.29-3.613-4.856-4.968
Operating Income Ratio -0.693-0.669-0.771-0.722-0.859-0.956-1.128-0.948-1.032-1.033-1.453-0.902-0.736-0.991-1.301-0.952-0.504-3.138-0.708-0.415-0.397-0.659-0.756
Total Other Income Expenses Net 0.177-1.3370.9730.279-0.262-0.1620.6640.59-0.241-0.189-0.093-0.383-0.267-0.0960.1610.232.6310.568-0.1470.096-0.34-0.649-0.819
Income Before Tax -13.952-15.242-13.563-13.64-14.841-16.055-15.736-14.037-14.172-14.6-15.761-12.854-10.137-12.297-11.978-9.276-3.811-11.855-7.076-4.522-4.246-5.505-5.786
Income Before Tax Ratio -0.684-0.733-0.719-0.708-0.84-0.934-1.083-0.91-1.05-1.047-1.461-0.938-0.764-1.008-1.296-0.944-0.359-3.228-0.821-0.437-0.466-0.747-0.88
Income Tax Expense 0.1920.0840.1860.2480.0590.140.1240.246-0.3830.040.0670.1520.0440.080.0670.0210.0490.0560.0870.1470.0890.0660.064
Net Income -14.144-15.326-13.749-13.888-14.9-16.195-15.86-14.283-13.789-14.64-15.828-13.006-10.181-12.377-12.045-9.297-3.86-11.911-7.163-4.669-4.335-5.571-5.85
Net Income Ratio -0.694-0.737-0.729-0.72-0.843-0.942-1.091-0.926-1.021-1.049-1.468-0.949-0.768-1.014-1.303-0.946-0.364-3.243-0.831-0.451-0.476-0.756-0.89
EPS -0.36-0.39-0.36-0.36-0.39-0.43-0.42-0.38-0.37-0.4-0.43-0.35-0.28-0.34-0.34-0.27-0.11-0.39-0.35-0.23-0.21-3.26-3.42
EPS Diluted -0.36-0.39-0.36-0.36-0.39-0.43-0.42-0.38-0.37-0.4-0.43-0.35-0.28-0.34-0.34-0.27-0.11-0.39-0.35-0.23-0.21-3.26-3.42
EBITDA -14.129-13.505-14.013-13.532-13.948-15.191-15.165-13.678-13.886-14.377-15.563-12.655-9.93-12.091-11.761-9.009-2.708-10.826-6.061-3.96-3.691-4.777-4.889
EBITDA Ratio -0.693-0.65-0.743-0.702-0.789-0.884-1.043-0.887-1.028-1.031-1.443-0.923-0.749-0.991-1.272-0.916-0.255-2.947-0.703-0.383-0.405-0.649-0.744